Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate

被引:27
作者
Camacho, Orlando [1 ,2 ]
Rosales, Maria Carmela [1 ,2 ]
Shafi, Tariq [3 ]
Fullman, Jonathan [1 ,2 ]
Plummer, Natalie S. [1 ,2 ]
Meyer, Timothy W. [1 ,2 ]
Sirich, Tammy L. [1 ,2 ]
机构
[1] VA Palo Alto HCS, Dept Med, Palo Alto, CA 94304 USA
[2] Stanford Univ, Palo Alto, CA 94304 USA
[3] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
关键词
clearance; p-cresol sulfate; uremia; PROTEIN-BOUND SOLUTES; UREMIC TOXINS; REMOVAL; SERUM; COLON; CRESYLSULPHATE; ACCUMULATION; SEPARATION; MORTALITY; SORBENT;
D O I
10.1093/ndt/gfw100
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
The protein-bound solutes p-cresol sulfate (PCS) and indoxyl sulfate (IS) accumulate to high plasma levels in renal failure and have been associated with adverse events. The clearance of these bound solutes can be altered independently of the urea clearance by changing the dialysate flow and dialyzer size. This study tested whether a sustained difference in clearance would change the plasma levels of PCS and IS. Fourteen patients on thrice-weekly nocturnal hemodialysis completed a crossover study of two periods designed to achieve widely different bound solute clearances. We compared the changes in pre-dialysis plasma PCS and IS levels from baseline over the course of the two periods. The high-clearance period provided much higher PCS and IS clearances than the low-clearance period (PCS: 23 +/- 4 mL/min versus 12 +/- 3 mL/min, P < 0.001; IS: 30 +/- 5 mL/min versus 17 +/- 4 mL/min, P < 0.001). Despite the large difference in clearance, the high-clearance period did not have a different effect on PCS levels than the low-clearance period [from baseline, high: +11% (-5, +37) versus low: -8% (-18, +32), (median, 25th, 75th percentile), P = 0.50]. In contrast, the high-clearance period significantly lowered IS levels compared with the low-clearance period [from baseline, high: -4% (-17, +1) versus low: +22% (+14, +31), P < 0.001). The amount of PCS removed in the dialysate was significantly greater at the end of the high-clearance period [269 (206, 312) versus 199 (111, 232) mg per treatment, P < 0.001], while the amount of IS removed was not different [140 (87, 196) versus 116 (89, 170) mg per treatment, P = 0.15]. These findings suggest that an increase in PCS generation prevents plasma levels from falling when the dialytic clearance is increased. Suppression of solute generation may be required to reduce plasma PCS levels in dialysis patients.
引用
收藏
页码:1335 / 1341
页数:7
相关论文
共 46 条
[1]   Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover study [J].
Bammens, B ;
Evenepoel, P ;
Verbeke, K ;
Vanrenterghem, Y .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (02) :278-285
[2]   Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients [J].
Barreto, Fellype C. ;
Barreto, Daniela V. ;
Liabeuf, Sophie ;
Meert, Natalie ;
Glorieux, Griet ;
Temmar, Mohammed ;
Choukroun, Gabriel ;
Vanholder, Raymond ;
Massy, Ziad A. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (10) :1551-1558
[3]   Release of Uremic Retention Solutes from Protein Binding by Hypertonic Predilution Hemodiafiltration [J].
Boehringer, Falko ;
Jankowski, Vera ;
Gajjala, Prathibha R. ;
Zidek, Walter ;
Jankowski, Joachim .
ASAIO JOURNAL, 2015, 61 (01) :55-60
[4]   Removal of Protein-Bound, Hydrophobic Uremic Toxins by a Combined Fractionated Plasma Separation and Adsorption Technique [J].
Brettschneider, Falko ;
Toelle, Markus ;
von der Giet, Markus ;
Passlick-Deetjen, Jutta ;
Steppan, Sonja ;
Peter, Mirjam ;
Jankowski, Vera ;
Krause, Alfred ;
Kuehne, Sophie ;
Zidek, Walter ;
Jankowski, Joachim .
ARTIFICIAL ORGANS, 2013, 37 (04) :409-416
[5]   Serum β-2 microglobulin levels predict mortality in dialysis patients:: Results of the HEMO study [J].
Cheung, Alfred K. ;
Rocco, Michael V. ;
Yan, Guofen ;
Leypoldt, John K. ;
Levin, Nathan W. ;
Greene, Tom ;
Agodoa, Lawrence ;
Bailey, James ;
Beck, Gerald J. ;
Clark, William ;
Levey, Andrew S. ;
Ornt, Daniel B. ;
Schulman, Gerald ;
Schwab, Steven ;
Teehan, Brendan ;
Eknoyan, Garabed .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02) :546-555
[6]   Normal and Pathologic Concentrations of Uremic Toxins [J].
Duranton, Flore ;
Cohen, Gerald ;
De Smet, Rita ;
Rodriguez, Mariano ;
Jankowski, Joachim ;
Vanholder, Raymond ;
Argiles, Angel .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (07) :1258-1270
[7]   Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019
[8]   Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis [J].
Eloot, Sunny ;
Schneditz, Daniel ;
Cornelis, Tom ;
Van Biesen, Wim ;
Glorieux, Griet ;
Dhondt, Annemie ;
Kooman, Jeroen ;
Vanholder, Raymond .
PLOS ONE, 2016, 11 (01)
[9]   Does the Adequacy Parameter Kt/Vurea Reflect Uremic Toxin Concentrations in Hemodialysis Patients? [J].
Eloot, Sunny ;
Van Biesen, Wim ;
Glorieux, Griet ;
Neirynck, Nathalie ;
Dhondt, Annemieke ;
Vanholder, Raymond .
PLOS ONE, 2013, 8 (11)
[10]   Uremic toxins originating from colonic microbial metabolism [J].
Evenepoel, Pieter ;
Meijers, Bjorn K. I. ;
Bammens, Bert R. M. ;
Verbeke, Kristin .
KIDNEY INTERNATIONAL, 2009, 76 :S12-S19